STE Valuation

STERIS plc

Add to Watchlist

Advanced Chart

217.180

-5.760(-2.580%)

Overview
Forecast
Valuation

STE Relative Valuation

STE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, STE is overvalued; if below, it's undervalued.

Historical Valuation

STERIS plc (STE) is now in the Undervalued zone, suggesting that its current forward PE ratio of 21.28 is considered Undervalued compared with the five-year average of 25.04. The fair price of STERIS plc (STE) is between 231.53 to 274.04 according to relative valuation methord. Compared to the current price of 216.41 USD , STERIS plc is Undervalued By 6.53%.

Relative Value

Fair Zone

231.53-274.04

Current Price：216.41

6.53%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

3.19

P/B

Median3y

3.35

Median5y

3.55

3.59

FCF Yield

Median3y

2.47

Median5y

2.44

Competitors Valuation Multiple

The average P/S ratio for STE's competitors is 3.68, providing a benchmark for relative valuation. STERIS plc Corp (STE) exhibits a P/S ratio of 3.67, which is -0.21% above the industry average. Given its robust revenue growth of 5.61%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap